Dr.phil.nat. ID: 41411

Thorsten Rieckmann

graph of relations

Publications

  1. 2023
  2. Advances in molecular targeted therapies to increase efficacy of (chemo)radiation therapy

    Viktorsson, K., Rieckmann, T., Fleischmann, M., Diefenhardt, M., Hehlgans, S. & Rödel, F., 12.2023, In: STRAHLENTHER ONKOL. 199, 12, p. 1091-1109 19 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  3. Radiotherapy combined with docetaxel alters the immune phenotype of HNSCC cells and results in increased surface expression of CD137 and release of HMGB1 of specifically HPV-positive tumor cells

    Grottker, F., Gehre, S., Reichardt, C. M., Sengedorj, A., Jost, T., Rieckmann, T., Hecht, M., Gostian, A-O., Frey, B., Fietkau, R., Gaipl, U. S. & Rückert, M., 11.2023, In: NEOPLASIA. 45, p. 100944

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. Impaired DNA double-strand break repair and effective radiosensitization of HPV-negative HNSCC cell lines through combined inhibition of PARP and Wee1

    Oetting, A., Christiansen, S., Gatzemeier, F., Köcher, S., Bußmann, L., Böttcher, A., Stölzel, K., Hoffmann, A. S., Struve, N., Kriegs, M., Petersen, C., Betz, C., Rothkamm, K., Zech, H. B. & Rieckmann, T., 07.2023, In: CLIN TRANSL RAD ONCO. 41, p. 100630

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma

    Borgmann, M., Oetting, A., Meyer, F., Möckelmann, N., Droste, C., von Bargen, C. M., Möller-Koop, C., Witt, M., Borgmann, K., Rothkamm, K., Betz, C., Münscher, A., Clauditz, T. S. & Rieckmann, T., 07.2023, In: J CANCER RES CLIN. 149, 7, p. 3383-3393 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. G2 checkpoint targeting via Wee1 inhibition radiosensitizes EGFRvIII-positive glioblastoma cells

    Cetin, M. H., Rieckmann, T., Hoffer, K., Riepen, B., Christiansen, S., Gatzemeier, F., Feyerabend, S., Schoof, M., Schüller, U., Petersen, C., Mynarek, M., Rothkamm, K., Kriegs, M. & Struve, N., 29.01.2023, In: RADIAT ONCOL. 18, 1, 19.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. Src family kinase targeting in head and neck tumor cells using SU6656, PP2 and dasatinib

    Vu, A. T., Akingunsade, L., Hoffer, K., Petersen, C., Betz, C. S., Rothkamm, K., Rieckmann, T., Bussmann, L. & Kriegs, M., 01.2023, In: HEAD NECK-J SCI SPEC. 45, 1, p. 147-155 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. 2022
  9. Detection of stage I HPV-driven oropharyngeal cancer in asymptomatic individuals in the Hamburg City Health Study using HPV16 E6 serology - A proof-of-concept study

    Busch, C-J., Hoffmann, A. S., Viarisio, D., Becker, B. T., Rieckmann, T., Betz, C., Bender, N., Schroeder, L., Hussein, Y., Petersen, E., Jagodzinski, A., Schäfer, I., Burandt, E., Lang Kuhs, K., Pawlita, M., Waterboer, T. & Brenner, N., 11.2022, In: ECLINICALMEDICINE. 53, 101659.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. The dogma of Cetuximab and Radiotherapy in head and neck cancer - A dawn to dusk journey

    Krishnamurthy, S., Ahmed, I., Bhise, R., Mohanti, B. K., Sharma, A., Rieckmann, T., Paterson, C. & Bonomo, P., 05.2022, In: CLIN TRANSL RAD ONCO. 34, p. 75-81 7 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  11. Tissue Microarray Analyses Suggest Axl as a Predictive Biomarker in HPV-Negative Head and Neck Cancer

    Busch, C-J., Hagel, C., Becker, B., Oetting, A., Möckelmann, N., Droste, C., Möller-Koop, C., Witt, M., Blaurock, M., Loges, S., Rothkamm, K., Betz, C., Münscher, A., Clauditz, T. S. & Rieckmann, T., 05.04.2022, In: CANCERS. 14, 7, 1829.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. Increased replication stress and R-loop accumulation in EGFRvIII expressing glioblastoma present new therapeutic opportunities

    Struve, N., Hoffer, K., Weik, A-S., Riepen, B., Krug, L., Cetin, M. H., Burmester, J., Ott, L., Liebing, J., Gatzemeier, F., Müller-Goebel, J., Bußmann, L., Parplys, A. C., Unger, K., Mansour, W. Y., Schüller, U., Rieckmann, T., Petersen, C., Rothkamm, K., Short, S. C. & Kriegs, M., 12.03.2022, In: NEURO-ONCOL ADV. 4, 1, p. vdab180 vdab180.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. Patient derived ex vivo tissue slice cultures demonstrate a profound DNA double-strand break repair defect in HPV-positive oropharyngeal head and neck cancer

    Zech, H. B., Berger, J., Mansour, W. Y., Nordquist, L., von Bargen, C., Bußmann, L., Oetting, A., Christiansen, S., Möckelmann, N., Böttcher, A., Busch, C-J., Petersen, C., Betz, C., Rothkamm, K., Kriegs, M., Köcher, S. & Rieckmann, T., 03.2022, In: RADIOTHER ONCOL. 168, p. 138-146 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. Head and neck tumor cells treated with hypofractionated irradiation die via apoptosis and are better taken up by M1-like macrophages

    Wedekind, H., Walz, K., Buchbender, M., Rieckmann, T., Strasser, E., Grottker, F., Fietkau, R., Frey, B., Gaipl, U. S. & Rückert, M., 02.2022, In: STRAHLENTHER ONKOL. 198, 2, p. 171-182 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. A Lack of Effectiveness in the ATM-Orchestrated DNA Damage Response Contributes to the DNA Repair Defect of HPV-Positive Head and Neck Cancer Cells

    Köcher, S., Zech, H. B., Krug, L., Gatzemeier, F., Christiansen, S., Meyer, F., Rietow, R., Struve, N., Mansour, W. Y., Kriegs, M., Petersen, C., Betz, C., Rothkamm, K. & Rieckmann, T., 2022, In: FRONT ONCOL. 12, 765968.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. 2021
  17. Kinomic comparison of snap frozen and ex vivo-cultured head and neck tumors

    Berger, J., Zech, H. B., Hoffer, K., von Bargen, C. M., Nordquist, L., Bussmann, L., Gatzemeier, F., Busch, C-J., Möckelmann, N., Münscher, A., Betz, C. S., Petersen, C., Rothkamm, K., Rieckmann, T., Köcher, S. & Kriegs, M., 12.2021, In: ORAL ONCOL. 123, 105603.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. Analyzing tyrosine kinase activity in head and neck cancer by functional kinomics: Identification of hyperactivated Src-family kinases as prognostic markers and potential targets

    Bußmann, L., Hoffer, K., von Bargen, C. M., Droste, C., Lange, T., Kemmling, J., Schröder-Schwarz, J., Vu, A. T., Akingunsade, L., Nollau, P., Rangarajan, S., de Wijn, R., Oetting, A., Müller, C., Böckelmann, L. C., Zech, H. B., Berger, J. C., Möckelmann, N., Busch, C-J., Böttcher, A., Gatzemeier, F., Klinghammer, K., Simnica, D., Binder, M., Struve, N., Rieckmann, T., Schumacher, U., Clauditz, T. S., Betz, C. S., Petersen, C., Rothkamm, K., Münscher, A. & Kriegs, M., 01.09.2021, In: INT J CANCER. 149, 5, p. 1166 - 1180 15 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. Dual Inhibition of PARP and the Intra-S/G2 Cell Cycle Checkpoints Results in Highly Effective Radiosensitization of HPV-Positive HNSCC Cells

    Hintelmann, K., Berenz, T., Kriegs, M., Christiansen, S., Gatzemeier, F., Struve, N., Petersen, C., Betz, C., Rothkamm, K., Oetting, A. & Rieckmann, T., 2021, In: FRONT ONCOL. 11, p. 683688

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. 2020
  21. Radiosensitisation and enhanced tumour growth delay of colorectal cancer cells by sustained treatment with trifluridine/tipiracil and X-rays

    Rothkamm, K., Christiansen, S., Rieckmann, T., Horn, M., Frenzel, T., Brinker, A., Schumacher, U., Stein, A., Petersen, C. & Burdak-Rothkamm, S., 28.11.2020, In: CANCER LETT. 493, p. 179-188 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. Improving the Efficacy of Tumor Radiosensitization Through Combined Molecular Targeting

    Hintelmann, K., Kriegs, M., Rothkamm, K. & Rieckmann, T., 04.08.2020, In: FRONT ONCOL. 10, p. 1260

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  23. Mass Spectrometric Comparison of HPV-Positive and HPV-Negative Oropharyngeal Cancer

    Wurlitzer, M., Möckelmann, N., Kriegs, M., Vens, M., Omidi, M., Hoffer, K., Bargen, C. V., Möller-Koop, C., Witt, M., Droste, C., Oetting, A., Petersen, H., Busch, C-J., Münscher, A., Schlüter, H., Clauditz, T. S. & Rieckmann, T., 11.06.2020, In: CANCERS. 12, 6

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  24. EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastoma

    Struve, N., Binder, Z. A., Stead, L. F., Brend, T., Bagley, S. J., Faulkner, C., Ott, L., Müller-Goebel, J., Weik, A-S., Hoffer, K., Krug, L., Rieckmann, T., Bußmann, L., Henze, M., Morrissette, J. J. D., Kurian, K. M., Schüller, U., Petersen, C., Rothkamm, K., O Rourke, D. M., Short, S. C. & Kriegs, M., 04.2020, In: ONCOGENE. 39, 15, p. 3041-3055 15 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. Dual PI3K/mTOR Inhibitor NVP-BEZ235 Enhances Radiosensitivity of Head and Neck Squamous Cell Carcinoma (HNSCC) Cell Lines Due to Suppressed Double-Strand Break (DSB) Repair by Non-Homologous End Joining

    Schötz, U., Balzer, V., Brandt, F-W., Ziemann, F., Subtil, F. S. B., Rieckmann, T., Köcher, S., Engenhart-Cabillic, R., Dikomey, E., Wittig, A. & Arenz, A., 18.02.2020, In: CANCERS. 12, 2

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. 2019
  27. Analyzing expression and phosphorylation of the EGF receptor in HNSCC

    Kriegs, M., Clauditz, T. S., Hoffer, K., Bartels, J., Buhs, S., Gerull, H., Zech, H. B., Bußmann, L., Struve, N., Rieckmann, T., Petersen, C., Betz, C. S., Rothkamm, K., Nollau, P. & Münscher, A., 19.09.2019, In: SCI REP-UK. 9, 1, p. 13564

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. The failure of cetuximab-based de-intensified regimes for HPV-positive OPSCC: A radiobiologists perspective

    Rieckmann, T. & Kriegs, M., 07.2019, In: CLIN TRANSL RAD ONCO. 17, p. 47-50 4 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  29. The inflammation-reducing compatible solute ectoine does not impair the cytotoxic effect of ionizing radiation on head and neck cancer cells

    Rieckmann, T., Gatzemeier, F., Christiansen, S., Rothkamm, K. & Münscher, A., 29.04.2019, In: SCI REP-UK. 9, 1, p. 6594

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  30. Modulation of radiation sensitivity and antitumor immunity by viral pathogenic factors: Implications for radio-immunotherapy.

    Rödel, F., Martin, D., Balermpas, P., Wieland, U., Winkelmann, R., Rieckmann, T., Falk, S., Rödel, C. & Fokas, E., 01.2019, In: BBA-REV CANCER. 1871, 1, p. 126-137 12 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  31. 2018
  32. Current studies of immunotherapy in head and neck cancer

    Dogan, V., Rieckmann, T., Münscher, A. & Busch, C-J., 02.2018, In: CLIN OTOLARYNGOL. 43, 1, p. 13-21 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  33. 2017
  34. Roscovitine strongly enhances the effect of olaparib on radiosensitivity for HPV neg. but not for HPV pos. HNSCC cell lines

    Ziemann, F., Seltzsam, S., Dreffke, K., Preising, S., Arenz, A., Subtil, F. S. B., Rieckmann, T., Engenhart-Cabillic, R., Dikomey, E. & Wittig, A., 01.12.2017, In: ONCOTARGET. 8, 62, p. 105170-105183 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  35. G2-checkpoint targeting and radiosensitization of HPV/p16-positive HNSCC cells through the inhibition of Chk1 and Wee1

    Busch, C-J., Kröger, M. S., Jensen, J., Kriegs, M., Gatzemeier, F., Petersen, C., Münscher, A., Rothkamm, K. & Rieckmann, T., 02.2017, In: RADIOTHER ONCOL. 122, 2, p. 260-266

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  36. 2016
  37. Perspectives in chemosensitivity and chemoresistance assays and their implementation in head and neck cancer

    Bussmann, L., Busch, C-J., Lörincz, B. B., Rieckmann, T., Block, A. & Knecht, R., 12.2016, In: EUR ARCH OTO-RHINO-L. 273, 12, p. 4073-4080

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  38. Targeted nanoparticles for tumour radiotherapy enhancement - the long dawn of a golden era?

    Gargioni, E., Schulz, F., Raabe, A., Burdak-Rothkamm, S., Rieckmann, T. & Rothkamm, K., 12.2016, In: ANN TRANSL MED. 4, 24, p. 523

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  39. Situation of young radiation oncologists, medical physicists and radiation biologists in German-speaking countries: Results from a web-based survey of the Young DEGRO working group

    Krug, D., Baumann, R., Rieckmann, T., Fokas, E., Gauer, T. & Niyazi, M., 01.08.2016, In: STRAHLENTHER ONKOL. 192, 8, p. 507-15

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  40. Radiosensitization of HNSCC cells by EGFR inhibition depends on the induction of cell cycle arrests

    Kriegs, M., Kasten-Pisula, U., Riepen, B., Hoffer, K., Struve, N., Myllynen, L., Braig, F., Binder, M., Rieckmann, T., Grénman, R., Petersen, C., Dikomey, E. & Rothkamm, K., 19.07.2016, In: ONCOTARGET. 7, 29, p. 45122-45133

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  41. Effect of sorafenib on cisplatin-based chemoradiation in head and neck cancer cells

    Möckelmann, N., Rieckmann, T., Busch, C-J., Becker, B., Gleißner, L., Hoffer, K., Omniczynski, M., Steinmeister, L., Laban, S., Grénman, R., Petersen, C., Rothkamm, K., Dikomey, E., Knecht, R. & Kriegs, M., 26.04.2016, In: ONCOTARGET. 7, 17, p. 23542-51 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  42. Similar cisplatin sensitivity of HPV-positive and -negative HNSCC cell lines

    Busch, C-J., Becker, B., Kriegs, M., Gatzemeier, F., Krüger, K., Möckelmann, N., Fritz, G., Petersen, C., Knecht, R., Rothkamm, K. & Rieckmann, T., 26.04.2016, In: ONCOTARGET. 7, 24, p. 35832-35842

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  43. DNA Repair

    Borgmann, K., Köcher, S., Kriegs, M., Mansour Khalfallah, W. Y., Parplys, A. C., Rieckmann, T. & Rothkamm, K., 2016, Molecular Radio-Oncology. Baumann, M., Krause, M. & Cordes, N. (eds.). 1 ed. Berlin Heidelberg: Springer, Vol. 198. p. 1-24 24 p. (Recent Results in Cancer Research).

    Research output: SCORING: Contribution to book/anthologySCORING: Contribution to collected editions/anthologiesResearchpeer-review

  44. DNA repair after oncological therapy (radiotherapy and chemotherapy)

    Dikomey, E., Borgmann, K., Kriegs, M., Mansour Khalfallah, W. Y., Petersen, C. & Rieckmann, T., 2016, Oxford Textbook of Oncology. Kerr, D. J., Haller, D. G., van de Velde, C. J. H. & Baumann, M. (eds.). 3 ed. Oxford: Oxford University Press, p. 82-85 4 p. Chapter 9

    Research output: SCORING: Contribution to book/anthologySCORING: Contribution to collected editions/anthologiesResearchpeer-review

  45. Radiation DNA damage and use in cancer/therapeutics-translation of radiation modifiers

    Dikomey, E., Borgmann, K., Köcher, S., Kriegs, M., Mansour Khalfallah, W. Y., Parplys, A. C., Rieckmann, T. & Rothkamm, K., 2016, DNA Repair in Cancer Therapy: Molecular Targets and Clinical Applications. Kelley, M. R. & Fishel, M. L. (eds.). 2 ed. London: Elsevier Science, p. 329 - 352 23 p. Chapter11

    Research output: SCORING: Contribution to book/anthologySCORING: Contribution to collected editions/anthologiesResearchpeer-review

  46. 2015
  47. EGFRvIII does not affect radiosensitivity with or without gefitinib treatment in glioblastoma cells

    Struve, N., Riedel, M., Schulte, A., Rieckmann, T., Grob, T. J., Gal, A., Rothkamm, K., Lamszus, K., Petersen, C., Dikomey, E. & Kriegs, M., 20.10.2015, In: ONCOTARGET. 6, 32, p. 33867-77 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  48. Radiosensitization of NSCLC cells by EGFR inhibition is the result of an enhanced p53-dependent G1 arrest

    Kriegs, M., Gurtner, K., Can, Y., Brammer, I., Rieckmann, T., Oertel, R., Wysocki, M., Dorniok, F., Gal, A., Grob, T. J., Laban, S., Kasten-Pisula, U., Petersen, C., Baumann, M., Krause, M. & Dikomey, E., 04.2015, In: RADIOTHER ONCOL. 115, 1, p. 120-7 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  49. HPV and Radiation Sensitivity

    De Costa, A-M., Rieckmann, T. & Kimple, R. J., 2015, Human Papillomavirus (HPV)-Associated Oropharyngeal Cancer. Miller, D. L. & Stack, M. S. (eds.). 1 ed. Springer, p. 243-289 47 p.

    Research output: SCORING: Contribution to book/anthologySCORING: Contribution to collected editions/anthologiesResearch

  50. 2014
  51. The inhibition of PARP but not EGFR results in the radiosensitization of HPV/p16-positive HNSCC cell lines

    Güster, J. D., Weissleder, S. V., Busch, C-J., Kriegs, M., Petersen, C., Knecht, R., Dikomey, E. & Rieckmann, T., 01.12.2014, In: RADIOTHER ONCOL. 113, 3, p. 345-51 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  52. 2013
  53. HPV-positive HNSCC cell lines but not primary human fibroblasts are radiosensitized by the inhibition of Chk1

    Busch, C-J., Kriegs, M., Laban, S., Tribius, S., Knecht, R., Petersen, C., Dikomey, E. & Rieckmann, T., 01.09.2013, In: RADIOTHER ONCOL. 108, 3, p. 495-9 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  54. Aberrant overexpression of miR-421 downregulates ATM and leads to a pronounced DSB repair defect and clinical hypersensitivity in SKX squamous cell carcinoma.

    Mansour Khalfallah, W. Y., Bogdanova, N. V., Kasten-Pisula, U., Rieckmann, T., Köcher, S., Borgmann, K., Baumann, M., Krause, M., Petersen, C., Hu, H., Gatti, R. A., Dikomey, E., Dörk, T. & Dahm-Daphi, J., 2013, In: RADIOTHER ONCOL. 106, 1, p. 147-154 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  55. HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity.

    Rieckmann, T., Tribius, S., Grob, T., Meyer, F., Busch, C-J., Petersen, C., Dikomey, E. & Kriegs, M., 2013, In: RADIOTHER ONCOL. 107, 2, p. 242-246 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  56. p53 modulates homologous recombination at I-SceI-induced double-strand breaks through cell-cycle regulation.

    Rieckmann, T., Kriegs, M., Nitsch, L., Hoffer, K., Rohaly, G., Köcher, S., Petersen, C., Dikomey, E., Dornreiter, I. & Dahm-Daphi, J., 2013, In: ONCOGENE. 32, 8, p. 968-975 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  57. 2012
  58. Radiation-induced double-strand breaks require ATM but not Artemis for homologous recombination during S-phase.

    Köcher, S., Rieckmann, T., Rohaly, G., Mansour, W., Dikomey, E., Dornreiter, I. & Dahm-Daphi, J., 2012, In: NUCLEIC ACIDS RES. 40, 17, p. 8336-8347 17.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  59. 2011
  60. Impact of HPV status on treatment of squamous cell cancer of the oropharynx: what we know and what we need to know.

    Tribius, S., Ihloff, A-S., Rieckmann, T., Petersen, C. & Hoffmann, M., 2011, In: CANCER LETT. 304, 2, p. 71-79 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  61. In tumor cells regulation of DNA double strand break repair through EGF receptor involves both NHEJ and HR and is independent of p53 and K-Ras status.

    Myllynen, L., Rieckmann, T., Dahm-Daphi, J., Kasten-Pisula, U., Petersen, C., Dikomey, E. & Kriegs, M., 2011, In: RADIOTHER ONCOL. 101, 1, p. 147-151 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  62. 2010
  63. Rapid fusion and syncytium formation of heterologous cells upon expression of the FGFRL1 receptor.

    Steinberg, F., Gerber, S. D., Rieckmann, T. & Trueb, B., 2010, In: J BIOL CHEM. 285, 48, p. 37704-37715 48.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  64. The epidermal growth factor receptor modulates DNA double-strand break repair by regulating non-homologous end-joining.

    Kriegs, M., Kasten-Pisula, U., Rieckmann, T., Holst, K., Saker, J., Dahm-Daphi, J. & Dikomey, E., 2010, In: DNA REPAIR. 9, 8, p. 889-897 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review